Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are a group of conditions where your bone marrow, the spongy tissue inside your bones that makes blood, doesn't produce enough healthy blood cells. In MDS, the stem cells in your bone marrow, which are meant to mature into red blood cells, white blood cells, and platelets, develop abnormally. This leads to a shortage of functional blood cells in your body and often the production of cells that are misshapen or don't work correctly. While not typically a cancer in its initial stages, MDS can sometimes progress to a more aggressive form of blood cancer called Acute Myeloid Leukemia (AML). The exact cause of MDS is often unknown, in which case it's called 'primary' or 'de novo' MDS. Researchers believe it involves acquired changes (mutations) in the DNA of bone marrow stem cells that occur over a person's lifetime. Less commonly, MDS can be 'secondary' or 'therapy-related,' developing after treatments like chemotherapy or radiation for a previous cancer. Exposure to certain environmental toxins, though rare, can also be a contributing factor. It's important to know that MDS is generally not inherited from your parents and is not contagious. Lab tests are essential for diagnosing and managing MDS, especially since early symptoms can be vague or even absent. Your doctor might have noticed abnormalities in your blood work, such as unusually low counts of red blood cells, white blood cells, or platelets, which prompted further investigation. Additional tests, including a bone marrow biopsy and genetic studies, are crucial to confirm a diagnosis, identify the specific type of MDS you have, understand its potential severity, and help your care team determine the most appropriate treatment plan tailored to your condition.